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Introduction:  The  inﬂuence  of  radiographic  bone  density  changes  in  the area surrounding  a  total  hip
arthroplasty  (THA)  revision  with  a cementless  press-ﬁt  stem  is  unknown,  notably  in terms  of  functional
results.  We  have  therefore  conducted  a  study  aiming  to  (1)  propose  a radiographic  method  to  assess
bone  density,  (2)  measure  the  functional  effects  of reduced  bone  density,  and  (3)  determine  the  factors
contributing  to these  modiﬁcations.
Hypothesis:  A  reduction  in  radiographic  bone  density  has  a negative  inﬂuence  on  the  functional  result
after  revision  using  a cementless  press-ﬁt  stem.
Material and  methods:  We  retrospectively  assessed  150  THA  revisions  at  a mean  follow-up  of
6.3  ±  3.2  years  (range,  2–15  years).  The  clinical  assessment  was  based  on  the  Harris  Hip  Score.  Bone  den-
sity modiﬁcations  were  measured  radiographically  and  the method  was  evaluated.  The  change  in bone
density  was  classiﬁed  into  two  groups:  (1) bone density  not  reduced  or < 2 Gruen  zones  (118  cases  [79%]);
(2)  bone  density  reduced  ≥ 2 zones  (32 cases  [21%]).  The  variables  showing  a potential  inﬂuence  were
the  Cortical  Index  (CI), the  type  of  primary  stability  with  the  press-ﬁt  system,  and the  femoral  implant
length.
Results:  Inter-  and intraobserver  reliability  of  radiographic  bone  density  measurement  was  evaluated  as
moderate  or  good  (Kappa,  0.58;  0.60  and  0.67,  respectively).  For  the Harris  Hip  Score  at follow-up,  there
was  a borderline  statistical  relation  between  stages  1 and  2: for the  118  stage  1 patients,  this  score  was
83.62  ±  11.54  (range,  27–99)  versus  78.34  ±  15.98  (range,  62–91)  for stage  2 patients  (P =  0.09).  A CI ≤ 0.44
showed  mediocre  bone  quality  contributing  to  decreased  bone  density  (P < 0.02).  On  the  other  hand,  there
was no  statistically  signiﬁcant  relation  with  the  type of  primary  ﬁxation  (P =  0.34)  or the  length  of the
implant  (P  = 0.23).
Conclusions:  A  cementless  revision  femoral  stem  can  induce  a reduction  in  bone  density  with  possible
functional  effects.  The  negative  role  played  by  bone  scarcity  on the  functional  score  is conﬁrmed,  and
even  though  the  difference  is not  statistically  signiﬁcant,  we  suggest  using  a short  stem  when  this  is
possible.
Level  of evidence:  Level  IV, historical  series.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. IntroductionThe femoral implant can be revised using a ﬁrst-line cementless
emoral stem, a distal interlocking prosthesis in cases with isthmic
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877-0568/© 2015 Elsevier Masson SAS. All rights reserved.lesions, a “ﬁt and ﬁll” prosthesis with extended porous coating [1],
or a press-ﬁt implant [2] stabilized by creating pressure greater
than the destabilizing forces at the bone–implant interface.
All cementless concepts can induce a reduction in bone den-
sity qualiﬁed as “stress shielding” by Engh et al. [3]. The authors
who have evaluated this [1,4,5] underscore the absence of a func-
tional effect of this bone density reduction, maintaining that it is
not clinically signiﬁcant. This can be contested and we  believe it is
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Fig. 1. Stage 1 bone density reduction. A. A 66-year-old female patient, global press-
ﬁt  stem. B. At the 6-year follow-up, the cortical thickness not modiﬁed but proximal
endofemoral approach and 36 extension with ﬂap), diaphyseal in84 F. Canovas et al. / Orthopaedics & Trauma
ertinent to check whether a reduction in bone density can have
n inﬂuence on the functional result after femoral revision with a
ementless press-ﬁt stem.
The objectives of this study were to:
propose a radiographic assessment of the changes in bone density
and to verify its reliability;
evaluate whether reduced bone density has a functional effect;
determine the main factors contributing to a decrease in bone
density.
We hypothesized that radiographically assessed bone density
eduction has a negative inﬂuence on the functional result.
. Patients and methods
.1. Patients
This retrospective study investigated a continuous series of
83 total hip arthroplasties performed between 1996 and 2000.
en patients who had died (6%) were excluded, six patients (3%)
ere lost to follow-up, and 17 patients (9%) questioned only by
elephone were autonomous and without pain. In the end, 150
rotheses (82%) in 143 patients (seven bilateral revisions) under-
ent complete radiological and clinical assessment by an observer
ho was not involved in the surgeries (MG), at a minimum of
 years follow-up. There were 74 females and 69 males (59 left
ips and 91 right hips). The mean age was 68.9 ± 9.1 years (range,
7–89 years) and the mean follow-up was 6.3 ± 3.2 years (range,
–15 years).
The causes for revision were: 79 cases of aseptic femoral implant
oosening (53%), 47 extensive femoral granulomas (31%), 21 cases
f cup loosening with femoral revision to change the bearing com-
onents (14%), two periprosthetic fractures, and one case of femoral
tem breakage.
According to Della Valle and Paprosky [6], bone loss was  stage
 for 55 cases (37%), stage 2 for 32 cases (22%), stage 3A for 38
ases (26%), stage 3B for 21 cases (14%), and stage 4 for two cases
1%). The two periprosthetic fractures were excluded from this
lassiﬁcation.
For 20 patients (13%) this was the second occurrence of loos-
ning and for four patients (3%) the third revision. The explanted
emoral stem was cemented in 140 cases (93%) and 19 cups were
ot changed.
.2. Surgical technique
All surgeries were performed by a single operator (PLB). The
pproach to the joint was anterolateral in 26 cases and pos-
erolateral in 124. The original components were removed via
he endofemoral approach in 46 cases (31%) and with femoro-
omy using a lateral semicircular trochanteric-diaphyseal ﬂap
n 104 cases (69%), if necessary associated with osteotomy of
he medial cortex to extend the primary stability that origi-
ally was only diaphyseal. No bone grafting was necessary. The
mplant was a right cementless femoral stem, conical and modu-
ar (RevitanTM, Zimmer, Warsaw, IN, USA), in titanium alloy with
 ﬁnely sanded surface, osseointegratable over its entire length.
n the recovery period, partial weightbearing was allowed for
 weeks..3. Evaluation method
Bone density was radiographically analyzed immediately after
he revision surgery and at the last follow-up, with a standard orfemur bone density decrease < 2 zones. C. Bone density reduction more visible on
negative X-ray.
negative AP X-ray. This comparative analysis consisted in locating
demineralized areas characterized by, at the last follow-up, attenu-
ation or disappearance of cortical trabeculations and, for borderline
cases, performing a numerical evaluation of the gray level intensity
[2]. All the demineralized areas, with or without decreased cortical
thickness, were taken into account and classiﬁed according to how
extensive they were and taking the Gruen zones as reference [7].
Zone 7 was  included in zone 6 and cases of cortical necrosis were
excluded from the study. Two  stages were distinguished: stage 1,
bone density not decreased or < 2 zones (Fig. 1) and stage 2, bone
density reduction ≥ 2 zones (Figs. 2 and 3).
The preoperative and follow-up clinical assessment were based
on the Harris Hip Score [8] and compared in terms of bone quality
as well as the type of primary stability and implant length:
• bone quality was assessed using the Cortical Index (CI), which
adds the median and lateral cortical thickness divided by the
diameter of the diaphysis. This was a preoperative measurement
taken in the isthmic area, outside the loosening area. This index
was  deemed very good, CI ≥ 0.55, in 30 cases (20%); good, CI
between 0.45 and 0.54, in 46 cases (31%); moderate, CI between
0.35 and 0.44, in 56 cases (37%); poor, CI ≤ 0.34, in 18 cases (12%);
• the type of primary press-ﬁt ﬁxation was deﬁned based on the
immediate postoperative X-ray by the femur area where there
was  bicortical bone–implant contact. The primary ﬁxation was
proximal in 13 cases (9%), global in 53 cases (35%) (17 via the46 cases (31%), and with three-point contact in 38 cases (25%);
• three implant lengths were distinguished: short stems
(< 200 mm)  in 31 cases, long stems between 200 and 250 mm in
60 cases, and extra-long stems (> 250 mm)  in 59 cases.
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Fig. 2. Stage 2 bone density reduction. A. A 75-year-old female patient, preoperative CI poor at 0.30. B. Press-ﬁt proximal stem. C. At 7-year follow-up, bone density
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global or diaphyseal ﬁxation, there were 18 (72%) stems longer
than 200 mm versus seven stems (28%) shorter than 200 mm
(Table 2).
Table 1
Clinical bone density results according to Harris Hip Score [8].
Bone density Stage 1 (n = 118) Stage 2 (n = 32) P-value
Clinical results
Preoperative scores 47.23 46.66 0.83eduction ≥ 2 zones, cortical thickness not modiﬁed, CI zone with primary stabili
n  c′ .
.4. Measurements and statistical analyses
All the quantitative radiographic measurements were taken
sing EvalNet software (LeadToolsTM; LEAD Technologies, Inc.,
harlotte, NC, USA), with the precision conﬁrmed beforehand [9].
The inter- and intraobserver reliability study for the bone den-
ity measurement was conducted by two surgeons specialized in
ip surgery (TPH, MG)  on a sample of 100 X-rays from the group
f 150 patients. For the same surgeon, the two evaluations were
arried out 10 days apart. It was quantiﬁed using the intraclass
orrelation coefﬁcient (Fleiss type 2), with a 95% conﬁdence inter-
al (CI). An intraclass correlation coefﬁcient < 0.20 was  considered
oor, mediocre between 0.21 and 0.40, moderate between 0.41 and
.60, good between 0.61 and 0.80, and very good between 0.81 and
.00.
The statistical analysis was done using R software (R foun-
ation, http://www.r-project.org/). The quantitative variables are
resented with their mean ± standard deviation (range). The differ-
nce in pre- and postoperative Harris Hip Scores was tested using
he Student t-test. The qualitative variables were compared using
he chi-square test or the Fisher exact test for small samples. The
igniﬁcance level taken into account was 5%.
. Results
Interobserver reliability was estimated to be moderate at 0.58,
5% CI (0.41–0.77) and intraobserver reliability to be moderate at
.60, 95% CI (0.43–0.76) for observer 1 and good at 0.67, 95%CI
0.49–0.85) for observer 2.Changes in bone density occurred in 118 stage 1 cases (79%) and
n 32 stage 2 cases (21%) with 13 patients presenting cortical atro-
hy. The two groups were comparable for the approaches used (37
ases [31%] the endofemoral approach for stage 1 patients versus.32. D. Measurement of gray intensity in b and c: 50% reduction in bone density
ten cases [31%] for stage 2 patients [NS]) and cup change (13 cases
[11%] of cups not changed for stage 1 patients versus three cases
[9%] for stage 2 patients [NS]). The preoperative Harris Hip Score
for the 118 stage 1 patients was  47.23 ± 12.84 (range, 7–95) ver-
sus 46.66 ± 14.46 (range, 24–80) for the stage 2 patients (P = 0.83).
The Harris Hip Score at follow-up for the 118 stage 1 patients was
83.62 ± 11.54 (range, 27–99) versus 78.34 ± 15.98 (range, 62–91)
for stage 2 patients, with a trend toward signiﬁcance (P = 0.09)
(Table 1).
There was a relation between a decrease in bone density and
the CI value (p < 0.02): this index was  moderate to poor (≤ 0.44)
in 27 of the 32 stage 2 patients (84%) versus 47 of the 118 stage
1 patients (40%). No relation was  found between the reduction
in bone density and the type of primary ﬁxation (P = 0.34). It can
nonetheless be noted that among the 32 stage 2 patients, 25
(78%) had global or diaphyseal ﬁxation versus seven (22%) patients
presenting a proximal primary or three-point ﬁxation. Finally,
there was no relation between reduced bone density and implant
length (P = 0.23). However, it should be noted that among the
25 patients presenting decreased bone density who had receivedScores at last follow-up 83.62 78.34 0.09
Modiﬁcations +36.39 +31.68 0.17
Stage 1: bone density reduction < 2 Gruen zones; Stage 2: bone density reduction > 2
zones.
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Fig. 3. Stage 2 bone density reduction. A. A 71-year-old female patient, preoperative
SI poor at 0.30. Long press-ﬁt diaphyseal stem. B. At 8-year follow-up, bone den-
sity reduction ≥ 2 zones, cortical thickness reduced with CI zone primary stability
reduced by 0.31 to 0.26.
Table 2
Results of correlation analysis.
Bone density Stage 1 (n = 118) Stage 2 (n = 32) P-value
Cortical Index < 0.02
Very good to good
CI ≥ 0.45 (n = 76)
71 (60%) 5 (16%)
Moderate to poor
CI ≤ 0.44 (n = 74)
47 (40%) 27 (84%)
Types of primary stability 0.34
Proximal (n = 13) 12 (10%) 1 (3%)
Global (n = 53) 38 (32%) 15 (47%)
Diaphyseal (n = 46) 36 (30%) 10 (31%)
3-Point (n = 38) 32 (27%) 6 (19%)
Implant length 0.23
Short < 200 mm (n = 31) 24 (20%) 7 (22%)
Long < 200–250 mm
(n = 60)
51 (44%) 9 (28%)
Extra-long > 250 mm
(n = 59)
43 (36%) 16 (50%)
Stage 1: bone density reduction < 2 Gruen zones; Stage 2: bone density reduction > 2
zones.: Surgery & Research 101 (2015) 283–287
4. Discussion
Decreased bone density around a femoral implant is often
reported. To measure this, researchers [1,4,5,10,11] use radio-
graphic evaluation and the radiographic classiﬁcation reported by
Engh et al. [3]. This classiﬁcation is not easy to use however: Gruen
zone 7 occupies an important place, although it is often absent dur-
ing revision or in the case of ﬁrst-intention reduced height, and
reduced bone density located in the distal femur with the prox-
imal femur intact cannot be taken into account. In addition, the
distinction does not appear clearly between reduced bone den-
sity involving the entire cortical thickness and simple cancellous
bone formation of the endosteum [12] located at the bone–implant
interface. Finally, it should be emphasized that the term “stress
shielding” can also refer to the cortical thickening often located in
the distal femur that does not systematically show reduced cortical
bone density.
The ﬁrst limitation of our method is the absence of osteodensit-
ometry measurement, most particularly to screen for bone mineral
density loss at its beginnings. To attenuate this disadvantage, we
used a numerical evaluation of the gray intensity and a negative
X-ray to better visualize the demineralized zones (Fig. 1) and to
take into account a reduction in bone density wherever it may
be located. Moreover, when osteopenia occurs, it usually comes
with thinned cortices with a wide medullary canal and, in these
conditions, the CI can also reﬂect a mediocre bone quality when
it is evaluated as moderate or poor. The problem of systemati-
cally requiring osteodensitometry in routine practice should also
be taken into account, notably for large series. Finally, the present
study investigated only one type of implant with no hydroxyapatite
(HA) coating and no bone grafting. The impact of these two  fea-
tures on bone density could not be evaluated and the conclusions
of Iwana et al. [4], who believe that HA coating could encourage
stress shielding, could not be conﬁrmed.
The reliability of our radiographic bone density measurement is
satisfactory and the 32 cases (21%) of bone density decrease greater
than 2 Gruen zones need to be compared with the results given by
Krishnamurthy et al. [5], who observed 29% stress shielding in Engh
et al.’s [3] stages 3 and 4. As for the most advanced 13 cases (9%)
in the series, corresponding to Engh stage 4, this result should be
compared with the 6% observed by Paprosky et al. [1] and 7.6% by
Moreland and Bernstein [13].
Those authors [1,5,10], who assessed bone density reduction
using the method reported in Engh et al. [3], underscore that stress
shielding had no functional effect. This has not been formally con-
ﬁrmed by the present study, which in contrast tends to demonstrate
that a decrease in bone density, when extended over more than two
Gruen zones, could be a cause of poorer functional results. In addi-
tion, the size of the group and its homogeneity (a single implant,
a single surgeon) could reinforce this impression, which, however,
needs to be conﬁrmed.
Osteopenia that could induce a substantial reduction in bone
density of the femoral cortices has often been highlighted [1,5]
and, other than the functional repercussions, the problems caused
by this should be discussed. On the other hand, the primary ﬁx-
ation mode and the implant length were not discussed in detail
and even though the statistical analysis did not show a statistically
signiﬁcant relation between these two factors and bone density
reduction, two trends are apparent. One can also cite a possible
“preventive” role of primary proximal ﬁxation (a single case in
our series), while emphasizing that proximal bone grafting would
probably have facilitated this option in several cases of diaphyseal
ﬁxation. The higher frequency of primary global or diaphyseal ﬁx-
ation (25 cases) in the 32 stage 2 patients could result from greater
disturbed transmission of stresses in ﬂexion with the long stem,
leading to excessive stiffening of the bone–implant pair [14] (Fig. 3).
ology:
O
d
t
a
l
e
5
s
a
a
f
e
s
t
a
t
ﬁ
D
t
a
A
a
f
[
[
[
[F. Canovas et al. / Orthopaedics & Traumat
ther than choosing a short stem in these two situations (global or
iaphyseal ﬁxation), a stem could be proposed that stabilizes in
he frontal plane, which is also the neutral plane in the diaphyseal
rea [15]. If this option of a short stem is not possible a cement-
ess implant should be discussed, particularly if the CI has been
valuated as poor.
. Conclusions
Our method for radiographically measuring bone density
howed moderate to good reliability. During femoral revision with
 cementless press-ﬁt stem implant, the results tend to prove that
 reduction in bone density could be the cause of less satisfactory
unctional results. When planning the surgical strategy, the pres-
nce of osteopenia, which facilitates a reduction in bone density,
hould be considered. Finally, and despite the absence of a statis-
ically signiﬁcant relation between the reduction in bone density
nd the type of ﬁxation and stem length, the results of this study
end to prove the unfavorable role played by diaphyseal or global
xation and a long stem.
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